AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference

Rhea-AI Summary

AVITA Medical (NASDAQ: RCEL) will present at the Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4, 2025 at 8:30 a.m. EST. Management will be available for one-on-one investor meetings at the conference for registered attendees.

A live audio webcast of the presentation will be accessible under the Events & Presentations section of AVITA Medical's investor website at https://ir.avitamedical.com/events-and-presentations, and a replay will be available after the event.

VALENCIA, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced that the Company will present at the Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4, 2025, at 8:30 a.m. EST. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conference.

A live audio webcast of the presentation will be accessible under the Events & Presentations section of AVITA Medical's website at https://ir.avitamedical.com/events-and-presentations. A replay of the webcast will be available following the conclusion of the event.

About AVITA Medical, Inc.

AVITA Medical^® is a leading therapeutic acute wound care company delivering transformative solutions. Our technologies are designed to optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of our platform is the RECELL^® System, approved by the U.S. Food and Drug Administration for the treatment of thermal burn and trauma wounds. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin™ Cells, offering an innovative solution for improved clinical outcomes at the point-of-care. In the U.S., AVITA Medical also holds the rights to manufacture and exclusive rights to market, sell, and distribute PermeaDerm^®, a biosynthetic wound matrix, and the exclusive rights to market, sell, and distribute Cohealyx™, an AVITA Medical-branded collagen-based dermal matrix.

In international markets, the RECELL System is approved to promote skin healing in a wide range of applications, including thermal burn and trauma wounds, with regulatory clearances in Europe, and excluding RECELL GO, in Australia and Japan.

To learn more, visit  www.avitamedical.com.

Investor & Media Contact:
Ben Atkins
Phone +1-805 341 1571
investor@avitamedical.com | media@avitamedical.com

Authorized for release by the Chief Financial Officer of AVITA Medical, Inc.

FAQ

When will AVITA Medical (RCEL) present at the Piper Sandler 2025 healthcare conference?

AVITA Medical (RCEL) will present on Thursday, December 4, 2025 at 8:30 a.m. EST.

How can investors watch the AVITA Medical (RCEL) presentation on December 4, 2025?

Investors can listen to a live audio webcast via the Events & Presentations page at https://ir.avitamedical.com/events-and-presentations.

Will AVITA Medical (RCEL) make the Piper Sandler presentation available after the event?

Yes, a replay of the webcast will be available on the company’s Events & Presentations webpage following the event.

Can investors schedule one-on-one meetings with AVITA Medical (RCEL) management at the conference?

Yes, management will be available for one-on-one meetings with investors who are registered to attend the conference.

Where is the Piper Sandler 37th Annual Healthcare Conference presentation listed on AVITA Medical's site?

The presentation is listed under Events & Presentations on AVITA Medical's investor website at https://ir.avitamedical.com/events-and-presentations.

What is AVITA Medical's stock symbol and exchange for this conference announcement?

AVITA Medical is listed as RCEL on NASDAQ (also ASX: AVH).